Semaglutide is emerging as a wonder drug for management of various metabolic diseases. Originally approved for type 2 diabetes, this glucagon like peptide-1 (GLP-1) receptor agonist is now showing promise for treating obesity, non-alcoholic steatohepatitis (NASH), and neurodegenerative diseases like Alzheimer’s and Parkinson’s. Let’s explore the therapeutic potential of semaglutide and how it acts as …
Obesity has reached epidemic levels globally, with serious health and economic consequences. While lifestyle factors play a key role, genetics also influence a person’s susceptibility to weight gain or difficulty losing weight. An emerging field called pharmacogenomics is uncovering how genetics impacts response to medications that cause weight gain as a side effect, as well …
A new randomized, double-blind, placebo-controlled clinical trial provides evidence that a green coffee bean extract standardized to chlorogenic acids (CGA-7) can help with weight loss in healthy overweight adults. Key facts: CGA-7 supplementation for 12 weeks resulted in significant reductions in body weight, BMI, body fat percentage and fat mass compared to placebo. Improvements were …
A new systematic review and meta-analysis suggests that swapping out sugar-sweetened beverages (SSBs) for low- and no-calorie sweetened beverages (LNCSBs) may support modest weight loss and improve certain cardiometabolic factors. The study found that LNCSBs offer similar benefits to water, the standard substitution recommended by health authorities. Key findings: Replacing SSBs with LNCSBs was linked …
Obesity has been linked to faster brain aging, but can losing weight turn back the clock? A new study provides compelling evidence that shedding pounds through lifestyle changes may attenuate brain aging. Key facts: Participants lost an average of 5% of body weight after 18 months of diet and exercise Just 1% weight loss corresponded …
